175 related articles for article (PubMed ID: 25683330)
1. Structural determinants for the interactions between muscarinic toxin 7 and muscarinic acetylcholine receptors.
Xu J; Zhao H; Zheng Z; Wang Y; Niu Y; Wang H; Xu J; Lu Y; Chen H
J Mol Recognit; 2015 Apr; 28(4):239-52. PubMed ID: 25683330
[TBL] [Abstract][Full Text] [Related]
2. Muscarinic toxin 7 selectivity is dictated by extracellular receptor loops.
Kukkonen A; Peräkylä M; Akerman KE; Näsman J
J Biol Chem; 2004 Dec; 279(49):50923-9. PubMed ID: 15452105
[TBL] [Abstract][Full Text] [Related]
3. Interpreting the structural mechanism of action for MT7 and human muscarinic acetylcholine receptor 1 complex by modeling protein-protein interaction.
Xu J; Xu J; Chen H
J Biomol Struct Dyn; 2012; 30(1):30-44. PubMed ID: 22571431
[TBL] [Abstract][Full Text] [Related]
4. Molecular conversion of muscarinic acetylcholine receptor M(5) to muscarinic toxin 7 (MT7)-binding protein.
Rondinelli S; Näreoja K; Näsman J
Toxins (Basel); 2011 Nov; 3(11):1393-404. PubMed ID: 22174976
[TBL] [Abstract][Full Text] [Related]
5. Muscarinic acetylcholine receptor (mAChR) inhibitor from snake venom: interaction with subtypes of human mAChR.
Miyoshi S; Tu AT
Arch Biochem Biophys; 1999 Sep; 369(1):114-8. PubMed ID: 10462446
[TBL] [Abstract][Full Text] [Related]
6. Structure and selectivity engineering of the M
Maeda S; Xu J; N Kadji FM; Clark MJ; Zhao J; Tsutsumi N; Aoki J; Sunahara RK; Inoue A; Garcia KC; Kobilka BK
Science; 2020 Jul; 369(6500):161-167. PubMed ID: 32646996
[TBL] [Abstract][Full Text] [Related]
7. Understanding G Protein Selectivity of Muscarinic Acetylcholine Receptors Using Computational Methods.
Santiago LJ; Abrol R
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31653051
[TBL] [Abstract][Full Text] [Related]
8. Structural model of ligand-G protein-coupled receptor (GPCR) complex based on experimental double mutant cycle data: MT7 snake toxin bound to dimeric hM1 muscarinic receptor.
Marquer C; Fruchart-Gaillard C; Letellier G; Marcon E; Mourier G; Zinn-Justin S; Ménez A; Servent D; Gilquin B
J Biol Chem; 2011 Sep; 286(36):31661-75. PubMed ID: 21685390
[TBL] [Abstract][Full Text] [Related]
9. Recombinant expression of a selective blocker of M(1) muscarinic receptors.
Näsman J; Jolkkonen M; Ammoun S; Karlsson E; Akerman KE
Biochem Biophys Res Commun; 2000 May; 271(2):435-9. PubMed ID: 10799315
[TBL] [Abstract][Full Text] [Related]
10. Structural Insight into Specificity of Interactions between Nonconventional Three-finger Weak Toxin from Naja kaouthia (WTX) and Muscarinic Acetylcholine Receptors.
Lyukmanova EN; Shenkarev ZO; Shulepko MA; Paramonov AS; Chugunov AO; Janickova H; Dolejsi E; Dolezal V; Utkin YN; Tsetlin VI; Arseniev AS; Efremov RG; Dolgikh DA; Kirpichnikov MP
J Biol Chem; 2015 Sep; 290(39):23616-30. PubMed ID: 26242733
[TBL] [Abstract][Full Text] [Related]
11. The A- and B-type muscarinic acetylcholine receptors from Drosophila melanogaster couple to different second messenger pathways.
Ren GR; Folke J; Hauser F; Li S; Grimmelikhuijzen CJ
Biochem Biophys Res Commun; 2015 Jul; 462(4):358-64. PubMed ID: 25964087
[TBL] [Abstract][Full Text] [Related]
12. Snake toxins that bind specifically to individual subtypes of muscarinic receptors.
Potter LT
Life Sci; 2001 Apr; 68(22-23):2541-7. PubMed ID: 11392624
[TBL] [Abstract][Full Text] [Related]
13. Site-directed mutagenesis of m1-toxin1: two amino acids responsible for stable toxin binding to M(1) muscarinic receptors.
Krajewski JL; Dickerson IM; Potter LT
Mol Pharmacol; 2001 Oct; 60(4):725-31. PubMed ID: 11562434
[TBL] [Abstract][Full Text] [Related]
14. Structure-function studies of muscarinic acetylcholine receptors.
Leach K; Simms J; Sexton PM; Christopoulos A
Handb Exp Pharmacol; 2012; (208):29-48. PubMed ID: 22222693
[TBL] [Abstract][Full Text] [Related]
15. Muscarinic toxin-like proteins from cobra venom.
Kukhtina VV; Weise C; Muranova TA; Starkov VG; Franke P; Hucho F; Wnendt S; Gillen C; Tsetlin VI; Utkin YN
Eur J Biochem; 2000 Dec; 267(23):6784-9. PubMed ID: 11082188
[TBL] [Abstract][Full Text] [Related]
16. Different interactions between MT7 toxin and the human muscarinic M1 receptor in its free and N-methylscopolamine-occupied states.
Fruchart-Gaillard C; Mourier G; Marquer C; Stura E; Birdsall NJ; Servent D
Mol Pharmacol; 2008 Dec; 74(6):1554-63. PubMed ID: 18784346
[TBL] [Abstract][Full Text] [Related]
17. Subtype-specific antibodies for muscarinic cholinergic receptors. I. Characterization using transfected cells and avian and mammalian cardiac membranes.
Mayanil CS; Richardson RM; Hosey MM
Mol Pharmacol; 1991 Dec; 40(6):900-7. PubMed ID: 1758441
[TBL] [Abstract][Full Text] [Related]
18. Chemical synthesis of MT1 and MT7 muscarinic toxins: critical role of Arg-34 in their interaction with M1 muscarinic receptor.
Mourier G; Dutertre S; Fruchart-Gaillard C; Ménez A; Servent D
Mol Pharmacol; 2003 Jan; 63(1):26-35. PubMed ID: 12488533
[TBL] [Abstract][Full Text] [Related]
19. Subtype-specific changes in ligand binding properties after solubilization of muscarinic receptors from baculovirus-infected Sf9 insect cell membranes.
Rinken A
J Pharmacol Exp Ther; 1995 Jan; 272(1):8-14. PubMed ID: 7815368
[TBL] [Abstract][Full Text] [Related]
20. Influence of MT7 toxin on the oligomerization state of the M1 muscarinic receptor.
Marquer C; Fruchart-Gaillard C; Mourier G; Grandjean O; Girard E; le Maire M; Brown S; Servent D
Biol Cell; 2010 Apr; 102(7):409-20. PubMed ID: 20170475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
